aSMDC for fecal incontinence

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Jul 2021: Trial registered, NCT04976153
  2. 11 May 2022: Trial started, NCT04976153

The trials

NCT04976153: Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence

State
Under way
Phase
Phase 3
People
290 planned
Started
11 May 2022
Primary completion
31 Dec 2027
Arms
aSMDC
Results
None posted
  1. 26 Jul 2021: Trial registered
  2. 11 May 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.